These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
Bologna, Italy. This pivotal global role within the Global Value & Market Access team is responsible for shaping global market access, pricing, evidence-generation, and health policy strategies for Alfasigma’s specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans that support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working … Seguir leyendo
Raleigh, Carolina del Norte, Estados Unidos. Estamos buscando un asistente de prácticas altamente motivado y orientado a los detalles para incorporarse al equipo de Asuntos Médicos y Científicos y Acceso al Mercado. Este programa de prácticas ofrece una oportunidad única para adquirir experiencia práctica en los aspectos estratégicos y operativos de acceso al mercado en una empresa líder en ciencias de la vida. El asistente de prácticas apoyará iniciativas que garantizarán el acceso óptimo de los pacientes a innovaciones … Seguir leyendo
Remote, US. At iRhythm, you’ll have the opportunity to grow your skills and your career while impacting the lives of people around the world. iRhythm is shaping a future where everyone, everywhere can access the best possible cardiac health solutions. Every day, we collaborate, create, and constantly reimagine what’s possible. We think big and move fast, driven by our commitment … Seguir leyendo
Hyderabad, India. The Global HEOR Value Writing Senior Associate plays a critical role in supporting Amgen’s global market access strategy through high-quality Health Technology Assessment (HTA) deliverables. This role collaborates closely with team lead and Global HEOR Product Leads to ensure alignment with product strategy. The Value Writing Senior Associate develops Global Value Dossiers (GVDs), US AMCP dossiers, EU JCA … Seguir leyendo
Cambridge, MA, US. The Director, US Health Economics and Outcomes Research (HEOR) & Real World Evidence (RWE) is responsible for identifying real-world and economic evidence needs and developing the real-world, clinical, humanistic, and economic evidence generation plans in collaboration with internal business partners to support the value of our products for US healthcare providers, population-health decision makers, and other external … Seguir leyendo
OBTÉN ACCESO A 100% CON PRo
El libre acceso termina aquí
Solo ves 30% de roles, con un retraso de 7 días. Con la versión Pro, obtienes 100% de ellos al instante. 367 puestos abiertos para Miembros Pro hoy.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
Valoramos su privacidad. Utilizamos cookies para mejorar su experiencia en nuestro sitio web, personalizar contenidos y anuncios y analizar nuestro tráfico. Puede elegir qué cookies permite y retirar su consentimiento en cualquier momento. Para más información, consulte nuestra Política de cookies.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
